Company intelligence / Profile preview

HB Biotech

New York, New York, United Stateshbbiotechnology.com.au ↗

Ownership: Private
Development stage: Other

Overview

The company has developed a patented line of superabsorbent supplement products with visual proof of effectiveness for consumers. They have significant manufacturing partnerships and licensing/investment opportunities available. Products are already commercialized internationally except pending US approval.

Therapeutic areas: Other
Modalities: Supplement
Industry: Food & Nutrition

Partnerships

Significant manufacturing partners (not named)

Beyond the preview

Go deeper on HB Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HB Biotech.

Explore the full profile